Skip to content

    Recently Viewed


      Johnson & Johnson to Participate in the UBS Global Healthcare Conference

      Share Article
      share to

      New Brunswick, NJ (April 20th, 2022) -- Johnson & Johnson (NYSE: JNJ) will participate in the UBS Global Healthcare Conference on Tuesday, May 24th. Mathai Mammen, Executive Vice President, Pharmaceuticals R&D, will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at

      A webcast replay will be available approximately 48 hours after the live webcast.

      Press Contacts:
      Linda Fedow
      (732) 524-6071

      Investor Contacts:
      Raychel Kruper
      (732) 524-6164

      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.